Myoinositol and Metformin in the Prevention of Gestational Diabetes in High-Risk Patients: A Narrative Review
Open Access
- 12 September 2024
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (18) , 5387
Abstract
Our hypothesis is that myoinositol and metformin in pregnant women with high-risk factors for glucose intolerance would reduce insulin resistance and consequently lower the incidence of gestational diabetes mellitus (GDM), a metabolic disorder of pregnancy characterized by maternal hyperglycemia due to deficient response to physiological insulin resistance, which may have a negative impact on perinatal outcome and long-term sequelae. In recent years, this pathology has become increasingly important given the global obesity epidemic and the delay in becoming pregnant, especially in industrialized countries. For this reason, the attempt to prevent, rather than cure, gestational diabetes is particularly important. In addition to lifestyle changes (especially diet and doing more exercise), myoinositol and metformin are the most promising factors at the moment, although not all RCTs published so far agree on their real effectiveness. A review of the articles published so far allows us to assume, albeit with some distinctions, that they can play a positive role.Keywords
This publication has 48 references indexed in Scilit:
- Inositol supplementation for the prevention and treatment of gestational diabetes mellitus: a meta-analysis of randomized controlled trialsArchives of Gynecology and Obstetrics, 2023
- Prophylactic administration of metformin reduces gestational diabetes mellitus incidence in the high-risk populations: a meta-analysisIrish Journal of Medical Science (1971 -), 2023
- Metformin-induced changes of the gut microbiota in healthy young men: results of a non-blinded, one-armed intervention studyDiabetologia, 2019
- Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta-analysisDiabetologia, 2019
- Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol: a secondary analysis from 3 RCTsAmerican Journal of Obstetrics and Gynecology, 2018
- Potential role and therapeutic interests of myo-inositol in metabolic diseasesBiochimie, 2013
- Effects of metformin and thiazolidinediones on suppression of hepatic glucose production and stimulation of glucose uptake in type 2 diabetes: a systematic reviewDiabetologia, 2006
- Gestational diabetes: The consequences of not treatingAmerican Journal of Obstetrics and Gynecology, 2005
- Glucose inhibits myo-inositol uptake and reduces myo-inositol content in cultured rat glomerular mesangial cellsMetabolism, 1990
- Metformin in management of pregnant insulin-independent diabeticsDiabetologia, 1979